Pär Segerdahl investigates notions of nature and animal in animal ethics, animal welfare and philosophy, as well as in contemporary culture more generally. He holds a PhD in theoretical philosophy from Uppsala University (1993). He was a guest researcher at the Centre for Gender Research at Uppsala University from 2007-2009, and since 2013 he works part time there in the project “Becoming ‘human’: gender theory and animals in a more-than-human world”. Pär Segerdahl became associate professor of theoretical philosophy at Åbo Akademi Univeristy in 1998 and Uppsala University in 2001. He currently develops new ideas for research on how our ethical outlook changes when the world changes, for example, when new biotechnology emerges. All his work concerns, in one way or another, the question what philosophy is and what it means to philosophize. Pär Segerdahl is involved in research communication for the BBMRI.se (Biobanking and Biomolecular Resources Research Infrastructure Sweden) and editor of The Ethics Blog and Etikbloggen. He is also a member of The Nordic Wittgenstein Society.
Telefon: 018-471 61 72
Pär Segerdahl on the Ethics Blog
- Consent based on trust rather than information? 2017-03-21
- Stem cells: unique biobank material? 2017-03-07
- Stem cell therapy remains a form of treatment 2017-02-27
- Commercialization, but not at any price 2017-02-14
- Not just facts, ideas are also needed 2017-02-08
- How should we think about it? 2017-01-24
- The pharmaceutical industry and altruism 2017-01-16
- Ethics and law of stem cell treatment of diabetes 2016-12-21
- Two researchers in neuroethics 2016-12-05
- The apparent academy 2016-11-29
ELSI-Service for BBMRI.se
We run the ELSI-Services for BBMRI.se (BioBanking and Molecular Resource Infrastructure of Sweden): a national effort for efficient and automated collection of biological material funded by the Swedish Research Council.
Handling incidental findings
How should we handle incidental findings in biobank and -omics research? Jennifer Viberg Johansson is looking at the arguments for and against disclosure of incidental findings.
Stem cell treatment of type 1 diabetes
We provide ethical and legal analysis and guidance on development of products for treating type 1 diabetes, using cells derived from human embryonic stem cells.
- Bioethics, vol. 30, ss. 203-209 DOI
- Language & Communication, vol. 42, ss. 36-49 DOI
- Ethics, Law and Governance of Biobanking .
- Nordic Wittgenstein Review, vol. 3, ss. 125-149
- European Journal of Human Genetics, vol. 22, ss. 437-441 DOI
- Ethics and the Philosophy of Culture, Newcastle: Cambridge Scholars Publishing. ss. 172-211
- Language, Ethics and Animal Life, New York and London: Bloomsbury Academic. ss. 16-31
- Crossing Boundaries, Leiden and Boston: Brill Academic Publishers. ss. 139-160
Thinking about ethics
Why would a cancer patient agree to test a drug that might not be effective on their own disease? And are researchers responsible if their research can be used to develop biological weapons? This collection of texts might not provide the answers, but at least give you some food for thought.
Pär Segerdahl invites you on a journey through some of the issues that the Ethics Blog has dealt with in the recent years. He writes about researchers’ responsibilities, about participating in research and about information and integrity. But he also writes about ethics as such: What is it today, really? In this book you can read about data protection and population based biobank studies. But you can also read about apes writing articles and about the risk with knowing the risk.
Biobank and registry ethics & law
For many years, researchers at CRB have provided constructive advise on how to deal with ethical and legal aspects of research using human tissue material and personal data. We have collaborated with biomedical scientists and published our findings in peer reviewed journals. As a summary of this research we have compiled a list of publications with abstracts. We have grouped them thematically to help you find the ones you might be interested in reading. Our publications deal with ethical frameworks and policy, regulatory aspects of biobank and registry research, informed consent, ethical review, integrity concerns, trust, genetic testing, indicental findings, commercialization, public and patient perceptions, rare diseases, children & biobanks & genetics, and biobank studies.
Philosophy, talking apes and social media
Most of us know Pär Segerdahl from the Ethics Blog where he invites readers to philosophize about research regulation, the meaning of consent, human-animal relationships, and what it means to think. Find out what has to say about philosophy, talking apes and social media.